[go: up one dir, main page]

CH458337A - Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstane - Google Patents

Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstane

Info

Publication number
CH458337A
CH458337A CH130464A CH130464A CH458337A CH 458337 A CH458337 A CH 458337A CH 130464 A CH130464 A CH 130464A CH 130464 A CH130464 A CH 130464A CH 458337 A CH458337 A CH 458337A
Authority
CH
Switzerland
Prior art keywords
androstanes
hydroxy
preparation
new substituted
substituted
Prior art date
Application number
CH130464A
Other languages
English (en)
Inventor
Julius Wechter William
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US256106A external-priority patent/US3132160A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH458337A publication Critical patent/CH458337A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH130464A 1963-02-04 1964-02-04 Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstane CH458337A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US256106A US3132160A (en) 1963-02-04 1963-02-04 3, 11-dioxygenated-17-desoxy-5beta-androstanes and processes therefor

Publications (1)

Publication Number Publication Date
CH458337A true CH458337A (de) 1968-06-30

Family

ID=22971116

Family Applications (1)

Application Number Title Priority Date Filing Date
CH130464A CH458337A (de) 1963-02-04 1964-02-04 Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstane

Country Status (5)

Country Link
CH (1) CH458337A (de)
DE (1) DE1242611B (de)
ES (1) ES296044A1 (de)
FR (1) FR3847M (de)
GB (1) GB998369A (de)

Also Published As

Publication number Publication date
ES296044A1 (es) 1964-04-01
GB998369A (en) 1965-07-14
FR3847M (fr) 1966-01-17
DE1242611B (de) 1967-06-22

Similar Documents

Publication Publication Date Title
AT260948B (de) Verfahren zur Herstellung neuer, substituierter Hydroxyhydrocarbyloxyalkylsiloxane
AT258302B (de) Verfahren zur Herstellung neuer 1,2-Dihydro-1,2,4-benztriazine
CH451169A (de) Verfahren zur Herstellung neuer substituierter Phenylamino-1,3-diazacyclopentene-(2)
CH441332A (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide
CH459196A (de) Verfahren zur Herstellung von 4,6-Pregnadienderivaten
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH443310A (de) Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone
AT249047B (de) Verfahren zur Herstellung neuer Benzamidobenzanilid-Derivate
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
CH471136A (de) Verfahren zur Herstellung neuer 1,3-Dihydro-5-aryl-2H-1,4-benzodiazepin-2-on-4-oxyde
AT280493B (de) Verfahren zur Herstellung neuer Gona-4,9,11-triene
CH505807A (de) Verfahren zur Herstellung neuer 8,14-seco-B-Homogonane
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
AT246741B (de) Verfahren zur Herstellung neuer N'-substituierter N-Arylsulfonyl-harnstoffe
CH458337A (de) Verfahren zur Herstellung neuer substituierter 3,11B-Hydroxy-5B-androstane
AT244953B (de) Verfahren zur Herstellung neuer 5-Nitro-2-furamidine
CH448337A (de) Verfahren zur Herstellung neuer 1-Amino-2-benzoyl-4-hydroxyanthrachinone
AT273074B (de) Verfahren zur Herstellung neuer 1,1-Dihydroxyphenylpropyl-3-thioäther
AT250967B (de) Verfahren zur Herstellung neuer Derivate des 1, 2-Malonyl-1, 2-dihydrocinnolins
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH471056A (de) Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden
CH464174A (de) Verfahren zur Herstellung von 2,6-Dichlor-4-nitrobenzamid